Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM)
2022 · ESMO Open · 11 citations
https://doi.org/10.1016/j.esmoop.2022.100567
L
Lorenzo Gervaso
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
91
Papers
746
Citations
11
h-index
15
i10-index
Lorenzo Gervaso is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Lung Cancer Research Studies & Neuroblastoma Research and Treatments. The author has an h-index of 11, co-authored 78 publications.
ORCID: 0000-0003-3313-8527Papers by this author
worksRole of the microbiome in the development and treatment of gastric cancer: an overview of the biological and clinical landscape
2024 · ESMO Gastrointestinal Oncology · 7 citations
https://doi.org/10.1016/j.esmogo.2024.100048
Investigating the Pathogenicity of Uncommon KRAS Mutations and Their Association with Clinicopathologic Characteristics in Patients with Colorectal Cancer
2024 · Journal of Molecular Diagnostics · 2 citations
https://doi.org/10.1016/j.jmoldx.2024.11.007
Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective study
2024 · ESMO Open · 1 citations
https://doi.org/10.1016/j.esmoop.2024.103662
Post-progression evaluation of patients treated with nivolumab for advanced non-small cell lung cancer: A prospective cohort analysis
2018 · Annals of Oncology · 0 citations
https://doi.org/10.1093/annonc/mdy486.016
1159P Molecular characterization of extra-pulmonary mixed adeno-neuroendocrine carcinomas: The NIRVANA substudy
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.1218
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat